Abstract: Two sets of new o-methoxyphenylpiperazine (MPP; series a) and 1,2,3,4-tetrahydroisoquinoline (THIQ; series b) derivatives, containing various imide moietiesderived from NAN190, were synthesized and evaluated in vitro for their ability to bind tothe serotonin 5-HT1A and 5-HT2A receptors. All new derivatives from series a demonstratedhigh 5-HT1A affinities, whereas THIQ analogues were much less active. With respect to5-HT2A receptors, three MPP derivatives presented moderate activity but the rest of theinvestigated compounds were practically inactive. The influence of changes in terminusgeometry on 5-HT1A receptor affinity was analyzed in regard to model compounds NAN190and MM199.
This is an open access article distributed under the
Creative Commons Attribution License which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
Export to BibTeX
MDPI and ACS Style
Bojarski, A.J.; Mokrosz, M.J.; Duszyńska, B.; Kozioł, A.; Bugno, R. New Imide 5-HT1A Receptor Ligands – Modification of Terminal Fragment Geometry. Molecules 2004, 9, 170-177.
Bojarski AJ, Mokrosz MJ, Duszyńska B, Kozioł A, Bugno R. New Imide 5-HT1A Receptor Ligands – Modification of Terminal Fragment Geometry. Molecules. 2004; 9(3):170-177.
Bojarski, Andrzej J.; Mokrosz, Maria J.; Duszyńska, Beata; Kozioł, Aneta; Bugno, Ryszard. 2004. "New Imide 5-HT1A Receptor Ligands – Modification of Terminal Fragment Geometry." Molecules 9, no. 3: 170-177.